Filana Therapeutics Inc.
FLNA | NASDAQ
$0.62
-$0.04 (-5.78%)
At close: Oct 30, 2026, 4:00 PM ET
$0.65
+$0.03 (+4.95%)
Pre-market:
Nov 2, 2026, 7:51 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 95.5M |
Short-Term Investments | n/a |
Long-Term Investments | n/a |
Other Long-Term Assets | n/a |
Receivables | 120K |
Inventory | n/a |
Other Current Assets | 1.59M |
Total Current Assets | 97.71M |
Property-Plant & Equipment | 20.65M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 20.65M |
Total Assets | 118.36M |
Account Payables | 6.4M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 35.81M |
Total Current Liabilities | 43.83M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 118K |
Total Long-Term Liabilities | 118K |
Total Liabilities | 43.95M |
Total Debt | n/a |
Book Value | 74.4M |
Book Value Per Share | 1.54 |
Common Stock | 48K |
Retained Earnings | -496.08M |
Comprehensive Income | n/a |
Shareholders Equity | 74.4M |
Total Investments | n/a |
Add to Watchlist
Select watchlists to add or remove FLNA